MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis

Kasivisvanathan, Veeru; Rannikko, Antti; Borghi, Marcelo; Panebianco, Valeria; A. Mynderse, Lance; H. Vaarala, Markku; Briganti, Alberto; Budäus, Lars; Hellawell, Giles; Hindley, Richard; J. Roobol, Monique; E. Eggener, Scott; Ghei, Maneesh; Villers, Arnauld; Bladou, Franck; Villeirs, Geert; Virdi, Jaspal; Boxler, Silvan; Robert, G.; B. Singh, Paras; Venderink, Wulphert; Hadaschik, Boris; Ruffion, A.; C. Hu, Jim; Margolis, Daniel; Crouzet, Sébastien; Klotz, Laurence; S. Taneja, Samir; A. Pinto, Peter; S. Gill, Inderbir; Allen, Clare; Giganti, Francesco; Freeman, Alex; Morris, Stephen; Punwani, Shonit; Williams, Norman; Brew‐Graves, Chris; J Deeks, Jonathan; Takwoingi, Yemisi; Emberton, Mark; M. Moore, Caroline

doi:10.1056/nejmoa1801993

Public

MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis

Published in New England Journal of Medicine • Mar 19, 2018

Authors:

Veeru Kasivisvanathan

Antti Rannikko

Marcelo Borghi

Abstract

BACKGROUND: Multiparametric magnetic resonance imaging (MRI), with or without targeted biopsy, is an alternative to standard transrectal ultrasonography-guided biopsy for prostate-cancer detection in men with a raised prostate-specific antigen level who have not undergone biopsy. However, comparativ...

Subject

Biopsy

Medicine

Prostate cancer

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!